Oncolytic Virotherapy

被引：57
|
作者：
Sze, Daniel Y. [1 ]
Reid, Tony R. [3 ]
Rose, Steven C. [2 ]
机构：
[1] Stanford Univ, Sch Med, Div Intervent Radiol, Stanford Canc Ctr, Stanford, CA 94305 USA
[2] Univ Calif San Diego, Div Intervent Radiol, San Diego, CA 92103 USA
[3] Univ Calif San Diego, Moores Canc Ctr, Div Med Oncol, La Jolla, CA 92093 USA
来源：
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY | 2013年 / 24卷 / 08期
关键词：
PHASE-I TRIAL; CLINICAL-TRIAL; REPLICATION-COMPETENT; ADENOVIRUS ONYX-015; VIRUS NV1020; I/II TRIAL; CANCER; INJECTION; THERAPY; JX-594;
D O I：
10.1016/j.jvir.2013.05.040
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
Oncolytic Virotherapy is an emerging technology that uses engineered viruses to treat malignancies. Viruses can be designed with biological specificity to infect Cancerous cells preferentially, and to replicate in these cells exclusively. Malignant cells may be killed directly by overwhelming viral infection and lysis, which releases additional viral particles, to infect neighboring cells and distant metastases. Viral infections may also activate the immune system,, unmask stealthy tumor antigens, and aid the immune system to recognize and attack neoplasms. Delivery of live virus particles is potentially complex, and may require the expertise of the interventional community.
引用
收藏
页码：1115 / 1122
页数：8
相关论文
共 50 条
  • [41] Mathematical analysis for oncolytic virotherapy
    Mohammadinejad, Hajimohammad
    Jani, Saeed
    Rabieimotlagh, Omid
    RIVISTA DI MATEMATICA DELLA UNIVERSITA DI PARMA, 2021, 12 (02): : 221 - 238
  • [42] Oncolytic Polio Virotherapy of Cancer
    Brown, Michael C.
    Dobrikova, Elena Y.
    Dobrikov, Mikhail I.
    Walton, Ross W.
    Gemberling, Sarah L.
    Nair, Smita K.
    Desjardins, Annick
    Sampson, John H.
    Friedman, Henry S.
    Friedman, Allan H.
    Tyler, Douglas S.
    Bigner, Darell D.
    Gromeier, Matthias
    CANCER, 2014, 120 (21) : 3277 - 3286
  • [43] MicroRNA Targeting for Oncolytic Virotherapy
    Kelly, Elizabeth J.
    Russell, Stephen J.
    MOLECULAR THERAPY, 2009, 17 : S97 - S98
  • [44] Progress of oncolytic virotherapy for neuroblastoma
    Chen, Xiao-Tong
    Dai, Shu-Yang
    Zhan, Yong
    Yang, Ran
    Chen, De-Qian
    Li, Yi
    Zhou, En-Qing
    Dong, Rui
    FRONTIERS IN PEDIATRICS, 2022, 10
  • [45] Oncolytic Virotherapy with Simultanously Enhanced Oncolytic Activity and Safety
    Jia, William J.
    MOLECULAR THERAPY, 2017, 25 (05) : 275 - 275
  • [46] Vaccinia virus and oncolytic virotherapy of cancer
    Thorne, SH
    Hwang, TH
    Kirn, DH
    CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2005, 7 (04) : 359 - 365
  • [47] Potentiation of oncolytic virotherapy with armed shRNA
    Guo, Wei
    Fang, Bingliang
    CANCER BIOLOGY & THERAPY, 2009, 8 (01) : 92 - 93
  • [48] Oncolytic Virotherapy of Canine and Feline Cancer
    Gentschev, Ivaylo
    Patil, Sandeep S.
    Petrov, Ivan
    Cappello, Joseph
    Adelfinger, Marion
    Szalay, Aladar A.
    VIRUSES-BASEL, 2014, 6 (05): : 2122 - 2137
  • [49] Optimizing oncolytic virotherapy in cancer treatment
    Harrington, Kevin
    Freeman, Daniel J.
    Kelly, Beth
    Harper, James
    Soria, Jean-Charles
    NATURE REVIEWS DRUG DISCOVERY, 2019, 18 (09) : 689 - 706
  • [50] The Potential of Oncolytic Virotherapy in Synovial Sarcoma
    Robinson, Steven I.
    Clark, Susan M.
    Iankov, Ianko D.
    Viker, Kimberly B.
    Concilio, Susanna C.
    Galanis, Evanthia
    MOLECULAR THERAPY, 2022, 30 (04) : 49 - 49
12345